NCT00260936|Completed
Metabolic Abnormalities - HIV Infected and Uninfected Males
Prevalence of Morphologic and Metabolic Anormalities in HIV Infected and Uninfected Young Men
Loading search results
Prevalence of Morphologic and Metabolic Anormalities in HIV Infected and Uninfected Young Men
Sponsor study identifier
observational
250
2 countries
13
Study Start
March 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2007
Actual (reported)Study Completion
August 2007
Actual (reported)To assess whether there exist significant differences in glucose metabolism, lipids, lactate, body composition, and bone density between HIV-infected and uninfected young men.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2007
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 30, 2005
Actual (reported)December 2, 2005
Actual (reported)March 2006
Date type not reportedThis date has not been verified as actual or estimated.
August 2007
Actual (reported)August 2007
Actual (reported)HIV-infected and -uninfected males, ages 12 to 24 years, of Tanner Stage 4 or 5
HIV-positive, has never been on ART
HIV-positive, currently on a non-PI-containing NNRTI-based regimen for at least 12 weeks. Must never have received a total of more than 6 months of PI-containing regimen, and at least one year must have passed since receipt of last PI-containing regimen
HIV-positive, currently on a non-NNRTI-containing PI-based regimen for at least 12 weeks. Must never have received a total of more than 6 months of NNRTI-containing regimen, and at least one year must have passed since receipt of last NNRTI-containing regimen.
Approximately 250 subjects will be enrolled in the study. The number of subjects enrolled in each study group will be as follows: 50 HIV-negative subjects; 100 HIV-positive subjects who are antiretroviral therapy (ART) naïve; and two groups of up to 50 HIV-positive subjects each, one on an NNRTI-based regimen and the other on a PI-based regimen.
Childrens Hospital of Los Angeles
Los Angeles, California, 90054, United States
University of California at San Diego
San Diego, California, 92093, United States
University of California at San Francisco
San Francisco, California, 94143, United States
Childrens Hopital National Medical Center
Washington D.C., District of Columbia, 20010, United States
Children's Diagnoistic and Treatment Center
Fort Lauderdale, Florida, 33301, United States
University of Miami
Miami, Florida, 33101, United States
University of South Florida
Grace Aldrovandi, MD
Children's Hospital Los Angeles
250 participants (actual enrollment reported by the registry).
First Submitted
November 30, 2005
First Posted
December 2, 2005
Study Start
March 2006
Date type not reportedThis date has not been verified as actual or estimated.
Study of Valproic Acid to Treat HIV Infected Adults
Contact the study team to confirm eligibility.
Tampa, Florida, 33606, United States
Stroger Hospital of Cook County
Chicago, Illinois, 60612, United States
Children's Hopsital of Boston
Boston, Massachusetts, 02115, United States
Mount Siani Medical Center
New York, New York, 10128, United States
Montefiore Medical Center
The Bronx, New York, 10467, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 02115, United States
University Pediatric Hospital
San Juan, 00936, Puerto Rico
Primary Completion
August 2007
Actual (reported)Study Completion
August 2007
Actual (reported)Last Updated
March 1, 2017
Record last verified: 2016-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: